NL6804983A - - Google Patents

Info

Publication number
NL6804983A
NL6804983A NL6804983A NL6804983A NL6804983A NL 6804983 A NL6804983 A NL 6804983A NL 6804983 A NL6804983 A NL 6804983A NL 6804983 A NL6804983 A NL 6804983A NL 6804983 A NL6804983 A NL 6804983A
Authority
NL
Netherlands
Application number
NL6804983A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL6804983A publication Critical patent/NL6804983A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL6804983A 1967-04-19 1968-04-09 NL6804983A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
NL6804983A true NL6804983A (es) 1968-10-21

Family

ID=25698043

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6804983A NL6804983A (es) 1967-04-19 1968-04-09

Country Status (17)

Country Link
US (1) US3531480A (es)
AT (2) AT292726B (es)
AU (2) AU5480173A (es)
BE (1) BE713802A (es)
BG (1) BG17326A3 (es)
CH (1) CH497458A (es)
DE (1) DE1770218A1 (es)
ES (1) ES352822A1 (es)
FR (1) FR1583822A (es)
GB (2) GB1223314A (es)
IE (2) IE32170B1 (es)
IL (2) IL29842A (es)
NL (1) NL6804983A (es)
NO (1) NO124997B (es)
OA (1) OA03386A (es)
RO (1) RO54395A (es)
SE (2) SE361884B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2059492A1 (es) * 1969-07-08 1971-06-04 Sandoz Sa

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6310059B1 (en) * 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
EP2019676A2 (en) * 2006-05-11 2009-02-04 Neuromed Pharmaceuticals, Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
MX2013010306A (es) 2011-03-08 2013-12-09 Zalicus Pharmaceuticals Ltd Formulaciones de dispersion solida y metodos de uso de las mismas.
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2059492A1 (es) * 1969-07-08 1971-06-04 Sandoz Sa

Also Published As

Publication number Publication date
GB1223315A (en) 1971-02-24
US3531480A (en) 1970-09-29
RO54395A (es) 1973-02-17
OA03386A (fr) 1970-12-15
BE713802A (es) 1968-10-17
AT292726B (de) 1971-09-10
FR1583822A (es) 1969-12-05
AU5480273A (en) 1973-07-12
IL29842A0 (en) 1968-06-20
IL29842A (en) 1971-05-26
GB1223314A (en) 1971-02-24
IE32170L (en) 1968-10-19
DE1770218A1 (de) 1971-10-14
SE356520B (es) 1973-05-28
IE32169B1 (en) 1973-05-02
AT293372B (de) 1971-10-11
ES352822A1 (es) 1969-11-16
SE361884B (es) 1973-11-19
CH497458A (de) 1970-10-15
AU5480173A (en) 1973-07-12
NO124997B (es) 1972-07-03
IE32169L (en) 1968-10-19
BG17326A3 (es) 1973-07-25
IL36239A (en) 1971-06-23
IE32170B1 (en) 1973-05-02

Similar Documents

Publication Publication Date Title
AU425114B2 (es)
FR1583822A (es)
AU416737B2 (es)
AU342066A (es)
FR7671M (es)
AU2454867A (es)
AU3151267A (es)
AU2977667A (es)
AU2528767A (es)
AU610966A (es)
AU2256867A (es)
AU2116667A (es)
AU408412B2 (es)
BE483855A (es)
BE162295A (es)
AU459699A (es)
BE426053A (es)
BE477645A (es)
BE711579A (es)
BE711494A (es)
BE707291A (es)
BE723944A (es)
BE711473A (es)
AU34866A (es)
BE711459A (es)